In vivo reprogramming and epigenetic rejuvenation of adult cardiomyocytes ameliorate heart failure in mice
暂无分享,去创建一个
Christina M. Tringides | D. Mooney | M. Mariotti | V. Gladyshev | Bohan Zhang | I. de Lázaro | Nadezhda E Makarova | Tiara L Orejón-Sánchez
[1] F. Casas,et al. A single short reprogramming early in life initiates and propagates an epigenetically related mechanism improving fitness and promoting an increased healthy lifespan , 2022, Aging cell.
[2] C. Shao,et al. In vivo partial cellular reprogramming enhances liver plasticity and regeneration , 2022, Cell reports.
[3] S. Horvath,et al. Genetic loci and metabolic states associated with murine epigenetic aging , 2022, bioRxiv.
[4] S. Horvath,et al. In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice , 2022, Nature Aging.
[5] M. Fraga,et al. Multi‐omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming , 2022, bioRxiv.
[6] H. Schöler,et al. Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice , 2021, Science.
[7] J. I. Izpisúa Belmonte,et al. In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche , 2021, Nature Communications.
[8] G. Cossu,et al. Transient reprogramming of postnatal cardiomyocytes to a dedifferentiated state , 2021, PloS one.
[9] Robert W. Williams,et al. Universal DNA Methylation Age Across Mammalian Tissues , 2021, bioRxiv.
[10] Soo Bin Kwon,et al. A mammalian methylation array for profiling methylation levels at conserved sequences , 2021, Nature Communications.
[11] Margarita V. Meer,et al. Reprogramming to recover youthful epigenetic information and restore vision , 2020, Nature.
[12] E. Cartwright,et al. Adenoviral Mediated Delivery of OSKM Factors Induces Partial Reprogramming of Mouse Cardiac Cells In Vivo , 2020 .
[13] V. Gladyshev. The Ground Zero of Organismal Life and Aging. , 2020, Trends in molecular medicine.
[14] Lei S. Qi,et al. Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells , 2020, Nature Communications.
[15] Yohan Kim,et al. Small-molecule-mediated reprogramming: a silver lining for regenerative medicine , 2020, Experimental & Molecular Medicine.
[16] S. Horvath,et al. DNA methylation aging clocks: challenges and recommendations , 2019, Genome Biology.
[17] M. Salih,et al. Cardiac-Specific Cre Induces Age-Dependent Dilated Cardiomyopathy (DCM) in Mice , 2019, Molecules.
[18] G. Cossu,et al. Non-viral, Tumor-free Induction of Transient Cell Reprogramming in Mouse Skeletal Muscle to Enhance Tissue Regeneration. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.
[19] H. Schöler,et al. Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo , 2018, Stem cells.
[20] D. Grimm,et al. AAV vector-mediated in vivo reprogramming into pluripotency , 2018, Nature Communications.
[21] Steve Horvath,et al. DNA methylation-based biomarkers and the epigenetic clock theory of ageing , 2018, Nature Reviews Genetics.
[22] Richard T. Lee,et al. Cardiomyocyte Regeneration: A Consensus Statement. , 2017, Circulation.
[23] G. Cossu,et al. Transient transcription factor (OSKM) expression is key towards clinical translation of in vivo cell reprogramming , 2017, EMBO molecular medicine.
[24] Peter Bankhead,et al. QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.
[25] C. R. Esteban,et al. In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming , 2016, Cell.
[26] R. Foo,et al. A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes From the Adult Mouse Heart. , 2016, Circulation research.
[27] Myungjae Song,et al. In Situ Pluripotency Factor Expression Promotes Functional Recovery From Cerebral Ischemia , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.
[28] Phillip A. Richmond,et al. Prolonged Cre expression driven by the α-myosin heavy chain promoter can be cardiotoxic. , 2015, Journal of molecular and cellular cardiology.
[29] M. Neeman,et al. ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation , 2015, Nature Cell Biology.
[30] M. Giacca,et al. In vivo activation of a conserved microRNA program induces mammalian heart regeneration. , 2014, Cell stem cell.
[31] N. Humphreys,et al. Generation of induced pluripotent stem cells from virus-free in vivo reprogramming of BALB/c mouse liver cells. , 2014, Biomaterials.
[32] Kostas Kostarelos,et al. In vivo cell reprogramming to pluripotency: exploring a novel tool for cell replenishment and tissue regeneration , 2014 .
[33] Jose M Polo,et al. Phases of reprogramming. , 2014, Stem cell research.
[34] Mario J. Garcia,et al. Cyclin A2 Induces Cardiac Regeneration After Myocardial Infarction Through Cytokinesis of Adult Cardiomyocytes , 2014, Science Translational Medicine.
[35] S. Horvath. DNA methylation age of human tissues and cell types , 2013, Genome Biology.
[36] M. Serrano,et al. Reprogramming in vivo produces teratomas and iPS cells with totipotency features , 2013, Nature.
[37] Kostas Kostarelos,et al. In Vivo Cell Reprogramming towards Pluripotency by Virus-Free Overexpression of Defined Factors , 2013, PloS one.
[38] P. Arlotta,et al. Direct lineage reprogramming of post-mitotic callosal neurons into corticofugal neurons in vivo , 2013, Nature Cell Biology.
[39] C. Lüscher,et al. In vivo reprogramming of circuit connectivity in postmitotic neocortical neurons , 2013, Nature Neuroscience.
[40] S. Ramaswamy,et al. A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells , 2012, Cell.
[41] K. Hochedlinger,et al. Efficient Generation of iPS Cells from Skeletal Muscle Stem Cells , 2011, PloS one.
[42] C. Lengner,et al. Reprogramming of Postnatal Neurons into Induced Pluripotent Stem Cells by Defined Factors , 2011, Stem cells.
[43] K. Hochedlinger,et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells , 2010, Nature Biotechnology.
[44] K. Hochedlinger,et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells , 2009, Nature Genetics.
[45] V. Beneš,et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.
[46] J. Whitsett,et al. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction , 2005, Nucleic acids research.
[47] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[48] E. Morkin. Control of cardiac myosin heavy chain gene expression , 2000, Microscopy research and technique.
[49] P. Douglas,et al. Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy , 2000, Nature Medicine.
[50] B. A. French,et al. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. , 1997, The Journal of clinical investigation.
[51] R. Wesselschmidt. The teratoma assay: an in vivo assessment of pluripotency. , 2011, Methods in molecular biology.
[52] K. Hochedlinger,et al. A reprogrammable mouse strain from gene-targeted embryonic stem cells , 2010, Nature Methods.